CK-16 Monoclonal Antibody

CK-16 Monoclonal Antibody

The CK-16 Monoclonal Antibody is a cutting-edge scientific breakthrough in the field of immunology. This highly specific antibody is designed to target and bind to the CK-16 protein, a key marker for various types of cancer cells. With its exceptional affinity and selectivity, this antibody offers a powerful tool for researchers and clinicians in the fight against cancer.

The CK-16 Monoclonal Antibody is meticulously engineered using state-of-the-art technology, ensuring its exceptional purity and stability. Its unique design allows for precise recognition and binding to the CK-16 protein, enabling accurate detection and analysis of cancer cells. This antibody is produced through a rigorous process, guaranteeing batch-to-batch consistency and reliability, making it an ideal choice for both research and diagnostic applications.

In addition to its exceptional specificity, the CK-16 Monoclonal Antibody also exhibits outstanding sensitivity, enabling the detection of even low levels of CK-16 protein expression. This attribute is particularly valuable in early cancer diagnosis and monitoring treatment response. Furthermore, this antibody is compatible with various experimental techniques, including immunohistochemistry, flow cytometry, and Western blotting, providing researchers with versatile options for their investigations.

The CK-16 Monoclonal Antibody represents a significant advancement in cancer research and diagnostics. Its exceptional specificity, sensitivity, and compatibility make it an invaluable tool for scientists and clinicians alike. With its ability to accurately detect and analyze CK-16 protein expression, this antibody opens up new possibilities for understanding cancer biology and developing targeted therapies. Trust in the CK-16 Monoclonal Antibody to revolutionize your research and contribute to the fight against cancer.